A phase I, double blind, three-way crossover study to assess the pharmacokinetic profile of cannabis based medicine extract (CBME) administered sublingually in variant cannabinoid ratios in normal healthy male volunteers (GWPK0215)

Authors
Category Primary study
JournalJournal of Cannabis Therapeutics
Year 2003
This article has no abstract
Epistemonikos ID: 4557e817c4f9ef8dc211049faa36f52a597a8ca1
First added on: Apr 03, 2025